TrialJournal of molecular medicine (Berlin, Germany)2017

Fenretinide differentially modulates the levels of long- and very long-chain ceramides by downregulating Cers5 enzyme: evidence from bench to bedside.

Dušan Garić et al.PubMed ↗Publisher ↗

No numbers read from the abstract.